The stock of Edwards Lifesciences Corp (NYSE:EW) last traded at $74.79, down -1.72% from the previous session.
EW stock price is now 2.91% away from the 50-day moving average and 5.96% away from the 200-day moving average. The market capitalization of the company currently stands at $43.87B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target maintained at $80, Piper Sandler recently Upgraded its rating from Neutral to Overweight for Edwards Lifesciences Corp (NYSE: EW). On January 30, 2025, Stifel Upgraded its previous ‘Hold’ rating to ‘Buy’ on the stock increasing its target price from $75 to quote $90, while ‘Wolfe Research’ rates the stock as ‘Underperform’
In other news, Chopra Daveen, CVP, TMTT sold 1,500 shares of the company’s stock on May 22 ’25. The stock was sold for $112,612 at an average price of $75.08. Upon completion of the transaction, the CVP, TMTT now directly owns 33,496 shares in the company, valued at $2.51 million. An SEC document containing details of the transaction can be found on the SEC’s website. On May 22 ’25, Officer Chopra Daveen bought 1,500 shares of the business’s stock. A total of $112,612 was incurred on buying the stock at an average price of $75.07. A total of 2.03% of the company’s stock is owned by insiders.
During the past 12 months, Edwards Lifesciences Corp has had a low of $58.93 and a high of $95.25. As of last week, the company has a debt-to-equity ratio of 0.07, a current ratio of 4.45, and a quick ratio of 3.66. According to the stock market information, the enterprise value for the company is $40735612928, which is based on a 49.97 price-to-earnings ratio, a 5.84 price-to-earnings-growth ratio, and a beta of 1.12. The fifty day moving average price for EW is $72.6734 and a two-hundred day moving average price translates $70.5807 for the stock.
The latest earnings results from Edwards Lifesciences Corp (NYSE: EW) was released for 2025-03-31. The net profit margin was 16.03% and return on equity was 16.73% for EW. The company reported revenue of $1.41 billion for the quarter, compared to $1.33 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 6.23 percent.
